Basic Information
VYNE Therapeutics is a late-stage biopharmaceutical company dedicated to the development and commercialization of serlopitant for the treatment of pruritus associated with dermatological conditions such as atopic dermatitis, psoriasis, and prurigo nodularis.
VYNE Therapeutics Inc.
NewHaven,Connecticut,United States of America
15~50 people
January 01, 2003
info@menlotx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios